Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured…
Reason Subpotent product:out of specification assay results observed during long term stability testing.
6 FDA recalls mention Cisatracurium. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Cisatracurium.
Reason Subpotent product:out of specification assay results observed during long term stability testing.
Reason Subpotent product:out of specification assay results observed during long term stability testing.
Reason Subpotent product:out of specification assay results observed during long term stability testing.
Reason Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride…
Reason Incorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label. The…
Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they…
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.